List of shareholders holding at least 5% of votes at the Company's Annual General Meeting on 27 June 2024

Current report no. 21/2024

Date of drafting: 1 July 2024

Subject: List of shareholders holding at least 5% of votes at the Company's Annual General Meeting on 27 June 2024.

Legal basis: Article 70(3) of the Public Offering Act - EGM list of over 5%

Report content:

The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław (the "Company"), provides a list of shareholders holding at least 5% of the number of votes at the Annual General Meeting of the Company held on 27 June 2024 (the "General Meeting"):

1. Michał Walczak, who was entitled to 1,471,145 votes, representing 35.79% of the votes at the General Meeting and accounting for 25.39% of the total number of votes;

2. Paweł Holstinghausen - Holsten, who was entitled to 950,041 votes, representing 23,11% of the votes at the General Meeting and accounting for 16.40% of the total number of votes;

3. Sylvain Cottens, who was entitled to 526,730 votes, representing 12.81% of the votes at the General Meeting and accounting for 9.09% of the total number of votes;

4. Nationale - Nederlanden Otwarty Fundusz Emerytalny, which was entitled to 340,662 votes, which accounted for 8.29% of the votes at the General Meeting and represents 5.88% of the total number of votes;

5. Funds managed by Towarzystwo Funduszy Inwestycyjnych Allianz Polska S.A., which were entitled to 474.987 votes, representing 11,56% of votes at the General Meeting and accounting for 8,2% of the total number of votes;

6. Funds managed by Powszechne Towarzystwo Emerytalne Allianz Polska S.A. (Allianz Polska Otwarty Fundusz Emerytalny and Allianz Polska Dobrowolny Fundusz Emerytalny), which were entitled to 230,154 votes, representing 5.6% of votes at the General Meeting and accounting for 3.97% of the total number of votes.